Mitomycin C/5-Fluorouracil Versus Cisplatin/5-Fluorouracil With Hyperfractionated Accelerated Radiotherapy in Locally Advanced Head and Neck Cancer: The ARO 04-01/AHMO Trial
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
Mitomycin C/5-Fluorouracil Versus Cisplatin/5-Fluorouracil With Hyperfractionated Accelerated Radiotherapy in Locally Advanced Head and Neck Cancer: The ARO 04-01/AHMO Trial. // International Journal of Radiation Oncology, Biology, Physics. – URL: https://www.sciencedirect.com/science/article/pii/S0360301626044640?dgcid=rss_sd_all
Mitomycin C/5-Fluorouracil Versus Cisplatin/5-Fluorouracil With Hyperfractionated Accelerated Radiotherapy in Locally Advanced Head and Neck Cancer: The ARO 04-01/AHMO Trial. International Journal of Radiation Oncology, Biology, Physics. https://www.sciencedirect.com/science/article/pii/S0360301626044640?dgcid=rss_sd_all
“Mitomycin C/5-Fluorouracil Versus Cisplatin/5-Fluorouracil With Hyperfractionated Accelerated Radiotherapy in Locally Advanced Head and Neck Cancer: The ARO 04-01/AHMO Trial.” International Journal of Radiation Oncology, Biology, Physics.
@article{article100417,
title = {Mitomycin C/5-Fluorouracil Versus Cisplatin/5-Fluorouracil With Hyperfractionated Accelerated Radiotherapy in Locally Advanced Head and Neck Cancer: The ARO 04-01/AHMO Trial},
journal = {International Journal of Radiation Oncology, Biology, Physics},
url = {https://www.sciencedirect.com/science/article/pii/S0360301626044640?dgcid=rss_sd_all}
}